According to Revolution Medicines
's latest financial reports the company has $1.85 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $1.85 B | 187.31% |
2022-12-31 | $0.64 B | 11.76% |
2021-12-31 | $0.57 B | 30.93% |
2020-12-31 | $0.44 B | 259.03% |
2019-12-31 | $0.12 B | 76.41% |
2018-12-31 | $69.58 M | 666.45% |
2017-12-31 | $9.07 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.20 B | -88.76% | ๐บ๐ธ USA |